- Home
- SOLV vs TECH Comparison
SOLV vs TECH Comparison
Compare SOLV & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOLV
- TECH
- Stock Information
- Founded
- SOLV 2023
- TECH 1976
- Country
- SOLV United States
- TECH United States
- Employees
- SOLV N/A
- TECH N/A
- Industry
- SOLV
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOLV
- TECH Health Care
- Exchange
- SOLV NYSE
- TECH Nasdaq
- Market Cap
- SOLV 11.5B
- TECH 12.0B
- IPO Year
- SOLV N/A
- TECH 1989
- Fundamental
- Price
- SOLV $73.48
- TECH $75.83
- Analyst Decision
- SOLV Hold
- TECH Buy
- Analyst Count
- SOLV 10
- TECH 8
- Target Price
- SOLV $68.29
- TECH $82.00
- AVG Volume (30 Days)
- SOLV 946.4K
- TECH 799.7K
- Earning Date
- SOLV 01-28-2025
- TECH 01-30-2025
- Dividend Yield
- SOLV N/A
- TECH 0.42%
- EPS Growth
- SOLV N/A
- TECH N/A
- EPS
- SOLV 4.16
- TECH 0.95
- Revenue
- SOLV $8,215,000,000.00
- TECH $1,171,583,000.00
- Revenue This Year
- SOLV $2.44
- TECH $7.67
- Revenue Next Year
- SOLV $0.38
- TECH $9.29
- P/E Ratio
- SOLV $17.66
- TECH $79.87
- Revenue Growth
- SOLV 0.60
- TECH 2.41
- 52 Week Low
- SOLV $47.16
- TECH $61.16
- 52 Week High
- SOLV $77.17
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- SOLV N/A
- TECH 55.66
- Support Level
- SOLV N/A
- TECH $73.67
- Resistance Level
- SOLV N/A
- TECH $78.44
- Average True Range (ATR)
- SOLV 0.00
- TECH 2.41
- MACD
- SOLV 0.00
- TECH 0.28
- Stochastic Oscillator
- SOLV 0.00
- TECH 66.02
About SOLV SOLVENTUM CORP
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.